| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Arizona Cancer Center [J. G. E., M. E. M., D. S. A.], Department of Surgery [R. S. K.], and Department of Surgical Pathology, Arizona Health Sciences Center [A. K. B.], University of Arizona, Tucson, Arizona 85724; Southern Arizona Veterans Affairs Health Care System, Tucson, Arizona 85723 [R. S. K.]; Response Genetics, Los Angeles, California 90033 [J. M. Y., K. D. D.]; and [J. M. Y., K. D. D.], Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center [P. V. D.], University of Southern California, Los Angeles, California 90033
The cyclooxygenase (COX) pathway is important in colorectal carcinogenesis with the majority of cancers overexpressing COX-2; however, the role of COX-2 in the development of colorectal adenomas is less well defined. Accordingly, we analyzed 108 colorectal adenomas for COX-1 and COX-2 transcription in archival formalin-fixed, paraffin-embedded tissue using by real-time PCR and normalized to ß-actin. Neither COX-1 nor COX-2 mRNA expression differed with regard to age or gender of the subject. COX-2 mRNA expression was significantly higher in distal adenomas (2.2 ± 1.9) compared with proximal (0.7 ± 0.5) adenomas (P < 0.0001) and in larger (
7 mm) compared with smaller (<7 mm) adenomas (2.3 ± 2.2 and 1.7 ± 1.3, respectively, P = 0.04). COX-2 expression did not differ significantly in tubular compared with tubulovillous adenomas, although there appeared to be a trend toward higher COX-2 expression in tubulovillous adenomas with increasing villous content. Additionally, there was not a significant difference in either COX-1 or COX-2 based on the degree of dysplasia Therefore, if COX-2 inhibitors work through a COX-2 mechanism, these agents may have differential effects on colorectal adenomas that are distal and larger.
This article has been cited by other articles:
![]() |
L. B. Sansbury, A. W. Bergen, K. L. Wanke, B. Yu, N. E. Caporaso, N. Chatterjee, L. Ratnasinghe, A. Schatzkin, T. A. Lehman, A. Kalidindi, et al. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 494 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Grau, J. A. Baron, E. L. Barry, R. S. Sandler, R. W. Haile, J. S. Mandel, and B. F. Cole Interaction of Calcium Supplementation and Nonsteroidal Anti-inflammatory Drugs and the Risk of Colorectal Adenomas Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2353 - 2358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nosho, M. Yoshida, H. Yamamoto, H. Taniguchi, Y. Adachi, M. Mikami, Y. Hinoda, and K. Imai Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis Carcinogenesis, May 1, 2005; 26(5): 892 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Hung, I.-J. Su, H.-Y. Lei, H.-C. Wang, W.-C. Lin, W.-T. Chang, W. Huang, W.-C. Chang, Y.-S. Chang, C.-C. Chen, et al. Endoplasmic Reticulum Stress Stimulates the Expression of Cyclooxygenase-2 through Activation of NF-{kappa}B and pp38 Mitogen-activated Protein Kinase J. Biol. Chem., November 5, 2004; 279(45): 46384 - 46392. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Taron, R. Rosell, E. Felip, P. Mendez, J. Souglakos, M. S. Ronco, C. Queralt, J. Majo, J. M. Sanchez, J. J. Sanchez, et al. BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer Hum. Mol. Genet., October 1, 2004; 13(20): 2443 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sato, K. Yoshinaga, S. Okabe, T. Okawa, T. Higuchi, M. Enomoto, T. Takizawa, and K. Sugihara Cyclooxygenase-2 Expression and its Relationship with Proliferation of Colorectal Adenomas Jpn. J. Clin. Oncol., December 1, 2003; 33(12): 631 - 635. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |